Authors :
Dr. Mohamed Ayub Sulaiman.H; Dr. Nagarajan.K
Volume/Issue :
Volume 9 - 2024, Issue 7 - July
Google Scholar :
https://tinyurl.com/yc4bph3c
Scribd :
https://tinyurl.com/29supf45
DOI :
https://doi.org/10.38124/ijisrt/IJISRT24JUL346
Abstract :
SIADH a condition where anti-diuretic
hormone (ADH) is secreted in the absence of appropriate
physiological stimuli. SIADH mostly characterized by
hypotonic, euvolemic hyponatremia with urinary
hyperosmolarity. SIADH is a well-known paraneoplastic
syndrome frequently linked with small-cell lung cancer
(SCLC).
References :
- Huber RM, Tufman A. Update on small cell lung cancer management. Breathe. 2012;8:314–330. doi: 10.1183/20734735.013211
- Nikoomanesh, K., Choi, J. & Arabian, S. Paraneoplastic syndrome as the presentation of limited stage small cell carcinoma. BMC Pulm Med 18, 169 (2018). https://doi.org/10.1186/s12890-018-0729-y
- Gandhi L, Johnson BE. Paraneoplastic syndromes associated with small cell lung cancer. J Natl Compr Canc Netw 4: 631-638, 2006
- A F List et al., The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) in small-cell lung cancer. JCO 4, 1191-8(1986). DOI:10.1200/JCO.1986.4.8.1191
SIADH a condition where anti-diuretic
hormone (ADH) is secreted in the absence of appropriate
physiological stimuli. SIADH mostly characterized by
hypotonic, euvolemic hyponatremia with urinary
hyperosmolarity. SIADH is a well-known paraneoplastic
syndrome frequently linked with small-cell lung cancer
(SCLC).
